That includes a night cream. I don’t use retinol nightly, so on the days I’m not applying an active I go into full reparative mode and layer as much moisture and as many healing ingredients as ...

GlaxoSmithKline said its key brands held their market share and continued to stay in line with the respective category performance. GlaxoSmithKline Pharmaceuticals on October 29 reported a 16 ...

Oct 29 (Reuters) - India's GlaxoSmithKline Pharmaceuticals (GLAX.NS), opens new tab reported a higher second-quarter adjusted profit on Tuesday, driven by strong demand for its generic drugs and ...

This is an instance where an eye cream could be incredibly helpful if not game-changing. That’s why I’ve chosen and organized picks based on concern rather than skin type. And to find the best ...

North Carolina is a leading place for biotech, and a big part of that success comes from GlaxoSmithKline (GSK). This global healthcare company has made a huge difference in the biotech scene here, ...

The consistency is smooth and silky and while not completely transparent, is definitely more of a gel consistency than a cream. It glides onto skin easily and has a slight cooling sensation but ...

There's nothing quite like patting on a little cream blush if you want to brighten up your complexion. Sure, finding the best highlighter will make your cheekbones beam, and investing in a ...

Moderna to defend against GSK's claims, spokesperson says GSK seeks unspecified monetary damages from Moderna A spokesperson for Massachusetts-based Moderna said the company was aware of the ...

(Reuters) -British drugmaker GlaxoSmithKline (NYSE:GSK) sued Moderna (NASDAQ:MRNA) in U.S. federal court in Delaware on Tuesday, accusing it of violating GSK patent rights in messenger RNA ...

(Reuters) -British drugmaker GlaxoSmithKline sued Moderna in U.S. federal court in Delaware on Tuesday, accusing it of violating GSK patent rights in messenger RNA technology with its blockbuster ...

By Blake Brittain (Reuters) -British drugmaker GlaxoSmithKline sued Moderna in U.S. federal court in Delaware on Tuesday, accusing it of violating GSK patent rights in messenger RNA technology ...